Phage display: an important tool in the discovery of peptides with anti-HIV activity

Biotechnol Adv. 2018 Nov 15;36(7):1847-1854. doi: 10.1016/j.biotechadv.2018.07.003. Epub 2018 Jul 17.

Abstract

Human immunodeficiency virus (HIV) remains a worldwide health problem despite huge investments and research breakthroughs, and no single drug is effective in killing the virus yet. Among new strategies to control HIV infection, the phage display (PD) technology has become a promising tool in the discovery of peptides that can be used as new drugs, or also as possible vaccine candidates. This review discusses basic aspects of PD and its use to advance two main objectives related to combating HIV-1 infection: the identification of peptides that inhibit virus replication and the identification of peptides that induce the production of neutralizing antibodies. We will cover the different approaches used for mapping and selection of mimotopes, and discuss the promising results of these biologicals as antiviral agents.

Keywords: HIV; Phage display; new drugs; vaccine candidates.

Publication types

  • Review

MeSH terms

  • Antibodies, Neutralizing / immunology
  • Antiviral Agents / immunology
  • Antiviral Agents / pharmacology*
  • Bacteriophages / genetics
  • Bacteriophages / metabolism*
  • Cell Surface Display Techniques / methods*
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / immunology*
  • HIV-1 / physiology
  • Humans
  • Peptide Library
  • Peptides / immunology
  • Peptides / pharmacology*
  • Virus Replication / drug effects

Substances

  • Antibodies, Neutralizing
  • Antiviral Agents
  • Peptide Library
  • Peptides